Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.64ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17039.2Germany
B.1.1.163ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17039.2Germany
JV.2SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-17029.2Japan
B.1.1.420SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-17029.2Japan
XCMSNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-17029.2Japan
DV.7.1.2SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-17029.2Japan
JV.1SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-17029.2Japan
KP.4.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17028.5South Korea
JN.1.59NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17028.5South Korea
JN.1.4.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17028.5South Korea
FL.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17028.5South Korea
BL.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17028.5South Korea
BF.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17028.5South Korea
B.1.177.75NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17028.5South Korea
XBB.1.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17028.5South Korea
BF.31.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17028.5South Korea
B.1.570NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17028.5South Korea
B.1.1.225ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-17020.5Japan
B.1.629ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-17020.5Japan
BK.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-17009France
BA.2.79NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-17007.8US
B.1.366NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-17007.8US
AY.70 (Delta)SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-16999.4Singapore
B.1.233NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-16998.3Japan
XBB.1.16.10NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-16994.8Japan
FB.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-16988.9US
BQ.1.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-16988.9US
FB.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-16988.9US
B.1.1.243NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-16987.7Thailand
AY.11 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-16987.7Thailand
BA.5.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
JC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
HN.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
MK.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
B.1.1.101ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
B.1.525 (Eta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
BA.2.77ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
B.1.443ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-16978.6China
B.1.570ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-16978.6China
B.1.554ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-16974.6China
B.1.1.315SYoung-STATACATGTCTCTGGGACCA20452176321782F-16970.4Singapore
B.1.389ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16962.5China
GU.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16962.5China
EG.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16962.5China
FY.1.2.1ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-16960.9China
B.1.39ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-16957.3China
CH.1.1.6NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-16954Germany
XBB.1.16.25NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-16953.8China
XCSNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-16953.8China
XBB.1.9.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-16947.8Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used